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Christopher A. Wootton, a Abraha Habtemariam, a Isolda Romero-Canelo´n, a
Feng Chen, a Guy J. Clarkson, a Ivan Prokes,a Lijiang Song,a
Peter B. O'Connor, a Volker Schu¨nemann b and Peter J. Sadler *a
The Cpx C–H protons in certain organometallic RhIII half-sandwich anticancer complexes [(h5-Cpx)Rh(N,N0)
Cl]+, where Cpx ¼ Cp*, phenyl or biphenyl-Me4Cp, and N,N0 ¼ bipyridine, dimethylbipyridine, or
phenanthroline, can undergo rapid sequential deuteration of all 15 Cp* methyl protons in aqueous media at
ambient temperature. DFT calculations suggest a mechanism involving abstraction of a Cp* proton by the
Rh–hydroxido complex, followed by sequential H/D exchange, with the Cp* rings behaving like dynamic
molecular ‘twisters’. The calculations reveal the crucial role of pp orbitals of N,N0-chelated ligands in
stabilizing deprotonated Cpx ligands, and also the accessibility of RhI–fulvene intermediates. They also
provide insight into why biologically-inactive complexes such as [(Cp*)RhIII(en)Cl]+ and [(Cp*)IrIII(bpy)Cl]+ do
not have activated Cp* rings. The thiol tripeptide glutathione (g-L-Glu-L-Cys-Gly, GSH) and the activated
dienophile N-methylmaleimide, (NMM) did not undergo addition reactions with the proposed RhI–fulvene,
although they were able to control the extent of Cp* deuteration. We readily trapped and characterized
RhI–fulvene intermediates by Diels–Alder [4+2] cyclo-addition reactions with the natural biological dienes
isoprene and conjugated (9Z,11E)-linoleic acid in aqueous media, including cell culture medium, the ﬁrst
report of a Diels–Alder reaction of a metal-bound fulvene in aqueous solution. These ﬁndings will introduce
new concepts into the design of organometallic Cp* anticancer complexes with novel mechanisms of action.Introduction
Methylated cyclopentadienyl ligands, and especially pentamethyl-
cyclopentadienyl (Cp*), are oen used as h5–p-bonded ligands in
transition metal complexes.1,2 Cp* and substituted Cp* (Cpx, e.g.
tetramethyl(biphenyl)cyclopentadienyl, CpxPhPh) ligands form
highly stable complexes with, for example, the low-spin d6 metal
ions RhIII and IrIII.3–6 Such RhIII and IrIII complexes are of interest
for their wide range of properties, including activity as catalysts
and anticancer agents,3,4,7–12 and sometimes as both.13,14
The biologically-active centre in half-sandwich [(h5-Cpx)Rh/
Ir(N,N0/C,N)Cl] anticancer complexes containing N,N0- or
C,N-chelated ligands is usually thought to be the metal ion
itself.10–14 Initial displacement of chloride by water (aquation)
can facilitate binding to target biomolecules, the possibility ofarwick, Gibbet Hill Road, Coventry CV4
erslautern, Erwin-Schro¨dinger-Straße 46,
ESI) available. CCDC 1420046–1420052
hic data in CIF or other electronic
hemistry 2018direct reactions involving the Cpx ligand under biologically-
relevant conditions has yet to be investigated.
In general C–H bonds in hydrocarbons are very stable and
diﬃcult to activate. They are only weakly acidic, and the avail-
able common bases are not strong enough.15,16 Such C–H bond
activation can be promoted especially by the electronic eﬀects of
platinum groupmetals, and numerous examples have now been
reported.17–21However, reported Cpx activation reactions usually
require harsh conditions.
In an early example, Kang and Maitlis deuterated the methyl
groups in the dinuclear RhIII complex [(Cp*)Rh(m2-OH)3-
Rh(Cp*)]Cl in D2O aer addition of OD
, but the process was
slow, requiring over 3 days at the elevated temperature of
343 K.22 At a similar time, Bercaw et al. used very strong bases in
non-polar solvents to synthesize Me4CpCH2–bridged Ti
II
complexes. These were sensitive to traces of water.23 Wei et al.
have shown that deuteration of the Cp* in [(Cp*)RhD2(BPin)]
(BPin ¼ bis(pinacolato)diboron) occurs readily in MeOD-d4 and
synthesized the deuterated compound [(D15Cp*)RhD2(BPin)],
under reux in D2O/OD
 for 3 days.24 Ciancaleoni et al. showed
that deuteration of [(Cp*)RhCl(PTA)2]
+ (PTA ¼ 7-phospha-1,3,5-
triaza-adamantane) is assisted by the basic centers in the PTA
ligand,25 and proposed a mechanism in which a Rh–OH species
deprotonates the Cp* ring followed by formation ofChem. Sci., 2018, 9, 3177–3185 | 3177
Chart 1 (a) RhIII and IrIII complexes studied here as PF6
 salts. (b)
Structures of glutathione, dienes and dienophile used in attempts to
trap fulvene intermediates.
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View Article Onlinea RhI–fulvene species, but no experimental evidence for the
fulvene complex was obtained.
Quintana et al.26 and Pitman et al.27 previously reported the
direct involvement of Cp* ligands in hydride transfer reactions.
In the former case, initial protonation of Cp* in the RhI catalyst
[(Cp*)Rh(bpy)] can lead to formation of H2 in dry acetonitrile. In
the latter case, [(Cp*H)Rh(bpy)Cl], generated by reduction of the
RhIII complex [(Cp*)Rh(bpy)Cl]+ followed by acidication in
ether, was isolated, and shown to reduce NAD+ to NADH. The
Cp* methyl protons underwent exchange with deuterium. Peng
et al. have recently characterized the RhI phenanthroline
analogue containing protonated Cp*, [(Cp*H)Rh(phen)Cl].28 A
recent report by Blakemore et al.29 introduced Cp*Rh
complexes of substituted 2,20-bipyridyl as eﬀective hydrogen
evolution catalysts involving the formation of unusual
h4-pentamethylcyclopentadiene–RhI intermediates under protic
conditions.
Our own investigations began with observations that in
aqueous solutions at ambient temperature, methyl 1H NMR
peaks of some [(Cp*)RhCl(N,N0)Cl]+ complexes which we had
synthesized as potential anticancer agents and transfer hydro-
genation catalysts, rapidly lost intensity, suggesting activation
towards H/D exchange under mild conditions. We have inves-
tigated the conditions under which this occurs, including the
inuence of solvent, aquation, and pH, and monitored the
reactions by both 1H NMR spectroscopy and high resolution FT
ICRMS spectrometry. We have also investigated the inuence of
substituents on the Cp* ligand (Cp* versus CpxPh and CpxPhPh),
inuence of the N,N0-chelating ligand (aliphatic ethylenedi-
amine (en) versus aromatic diamines bipyridyl (bpy),
4,40-dimethyl-2,20-bpyridine (mbpy), and phenanthroline
(phen)), as well as the metal ion (RhIII versus IrIII). The X-ray
crystal structures of 8 new complexes are reported.
We have used density functional theory (DFT) calculations to
elucidate the mechanism of these Cpx C–H activation reactions.
Importantly the DFT calculations led to the prediction of
accessible RhI–fulvene states and so we investigated the trap-
ping of such intermediates by addition reactions with thiols
(glutathione), dienes (N-methyl maleimide, NMM) and dien-
ophiles, Chart 1. The thiol tripeptide glutathione (g-L-Glu-L-Cys-Gly)
is present in cells at millimolar concentrations, and might be
expected to undergo addition reactions with double bonds such
as those in a fulvene, asmight NMMwhich contains an activated
double bond. Fulvene is known to undergo Diels–Alder reactions
with both dienes and dienophiles.30 The exocyclic double bond
of fulvene can also act as a dienophile in a Diels–Alder reac-
tion.30,31 The presence of substituents on the exocyclic double
bond shis the Diels–Alder reaction to the endocyclic double
bond.30,31 In attempts to trap adducts of the proposed fulvene
intermediate as [4+2] cyclo-addition Diels–Alder adducts, we
chose the natural biological conjugated dienes isoprene and
(9Z,11E)-linoleic acid (Chart 1). Isoprene is the most abundant
hydrocarbon in human breath, with an estimated human
production of 17 mg per day.32,33 (9Z,11E)-Linoleic acid is
a common dietary conjugated fatty acid, of particular interest for
its potential role in the prevention and treatment of a variety of3178 | Chem. Sci., 2018, 9, 3177–3185diseases,34 including roles in modulating the expression of
oncogenes and cell cycle regulators.34,35
The surprising success of these RhI–fulvene trapping reac-
tions under mild conditions of biological relevance is likely to
open up new avenues of investigation into reactions of this
class of half-sandwich organometallic complexes and inu-
ence their design as biologically-active agents. Our discovery
of Diels–Alder reactions of a metal-bound fulvene under
mild conditions in aqueous solutions, appears to be
unprecedented.Results and discussion
Synthesis and characterization of complexes
Organo–RhIII complexes 1 and 3–12 (Chart 1(a)) and IrIII
complex 2 containing Cp*, CpxPh or CpxPhPh, together with an
N,N0-chelated ligand (en, bpy, mbpy or phen), and a mono-
dentate chloride ligand were synthesized by the reaction of the
appropriate chloride-bridged dimer and chelating ligand,
except complex 12 which was prepared by substitution of
chloride in complex 1 by pyridine. They were fully characterized
by 1H NMR spectroscopy, ESI-mass spectrometry, and elemental
analysis (details in the ESI†). The X-ray crystal structures of
complexes 1, 3, 4, 6, 7, 9, 10 and 12 were determined (Fig. S1,
Tables S1 and S2†). All exhibit the typical ‘piano-stool’ geom-
etry. Rh–Cl distances are in the range of 2.385–2.403 A, with
complexes containing extended Cpx rings having slightly longer
bond lengths. The Rh–Cpx centroid distance of 1.778–1.795 A
shows little change with extension of the Cp* ring. Interestingly,
complexes 6, 7 and 9 have one Rh–N distance slightly longer
than the other, which might be due to the combined eﬀects of
crystal packing and ligand substituents. The bond lengths and
angles for complexes 6 and 7 are similar to those reported for
[(Cp*)Rh(phen)Cl]SO3CF3,36 and for complexes 1, 3 and 4 are
similar to those reported for [(Cp*)Rh(bpy)Cl]SO3CF3.36 For the
pyridine complex 12, the Rh–N(pyridine) bond (2.127(4) A) is
longer than other two Rh–N (bipyridine) bonds (ca. 2.105 A).This journal is © The Royal Society of Chemistry 2018
Fig. 1 Sequential deuteration of complex 1monitored by NMR and MS.
(a) 1H NMR spectrum of 1 after reaction with AgNO3 in 60% MeOD-d4/
40%D2O for 24 h, and FT-ICRmass spectrum after 72 h. (b) FT-ICRmass
spectra of 1 treated with 0.95 mol equiv. AgNO3 and incubated at
ambient temperature in 60% MeOD-d4/40% D2O. Isotopic pattern at
t¼ 0min corresponds to 1, and at t¼ 20, 40, 60 and 80 min to the sum
of isotopic patterns for 1 at various stages of deuteration.
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View Article OnlineHydrolysis
Aquation of chloride complexes 1 and 3–11 in 20% methanol-
d4/80% D2O (1.4 mM, 310 K) was conrmed by comparing
1H NMR spectra before and aer removal of the chloride ligand
by reaction with AgNO3. Complexes 1, 3–11 show fast hydrolysis
at 310 K, reaching equilibrium in <10 min. Complete conver-
sion of chloride complex 11 to the aqua adduct was observed,
whereas 1, and 3–10 reached equilibrium with 30–60% forma-
tion of the aqua species (Table S3†). pK*a values of the aqua
adducts of 1, 8, 11 were determined by 1H NMR. The pK*a values
for the RhIII complexes of 8.8–9.4 (Table S3†) are, ca. 1–2 pKa
units higher than for the IrIII analogue 2.13 The pyridine
complex 12 showed only ca. 10% hydrolysis even aer 10 days
under similar experimental conditions.
When rhodium complexes 1 and 3–10 were dissolved in 60%
MeOD-d4/40% D2O and reacted with AgNO3 to generate the
corresponding aqua adducts, the 1H NMR spectra aer 24 h at
310 K showed the expected peaks for the chelated ligands
(bipyridine, phenanthroline or 4,40-dimethyl-2,20-bipyridine),
but resonances corresponding to the methyl protons in the Cp*,
CpxPh and CpxPhPh ligands were not observed as the expected
sharp singlets, but as broad signals, diﬃcult to distinguish
from the baseline (Fig. 1a, S2†). To identify the species formed,
the FT-ICRMS spectrum of each product was recorded aer 72 h
(Fig. 1a). The MS peaks were assignable to the deuterated-Cpx
forms of complexes 1 and 3–10. Hence, facile deuteration of the
cyclopentadienyl ligands of these complexes occurs under very
mild conditions. Notably however, we observed no deuteration
of Ir–bpy complex 2, nor Rh–en complex 11 (Fig. S3†).Sequential deuteration
Experiments were then performed to investigate the conditions
under which deuteration occurs, in particular the eﬀect of time,
pH, solvent, hydrolysis and use of AgI to remove the Cl ligand.
1H NMR spectra of a 1.4 mM solution of complex 1 in 60%
MeOD-d4/40% D2O treated with Ag
I were recorded at ambient
temperature aer 50 min and then every 410 s. A gradual
decrease in intensity, with splitting and broadening of the Cpx
methyl peaks was observed. FT-ICR MS spectra were recorded
every 10 min for 80 min and then aer 27 and 42 h. Gradual
deuteration of the Cpx ring methyls was observed and it was
evident that deuteration occurs via sequential replacement of
methyl protons by deuterium from D1 to D15, complete
deuteration (Fig. 1b).
Deuteration of Cp* ring methyls of 1 occurred both in the
presence and absence of AgI (Fig. S4†). In the absence of AgI, 30–
50% hydrolysis was observed as a fast exchange on the NMR
timescale. Addition of chloride suppressed both the hydrolysis
and deuteration (Fig. S5†). Hence, we concluded that the
formation of the Rh–aqua adduct is crucial for the deuteration.
The presence of methanol increased the rate of deuteration
of 1 (Fig. S6†), increasing from 6% in D2O, to 20% in 40%
D2O/60% MeOD-d4 to 66% in MeOD-d4 alone, aer ca. 19 h at
293 K. Further evidence for involvement of the Rh–aqua
complex in ring methyl deuteration was provided by [h5-(Cp*)
Rh(bpy)(py)](PF6)2 (12). The X-ray crystal structure (Fig. S1,This journal is © The Royal Society of Chemistry 2018Table S2†) shows a strong Rh–N(pyridine) bond (2.127(4) A),
and even aer 10 days at 310 K in 60% MeOD-d4/40% D2O, only
2 D had been incorporated into the Cp*, attributable to a small
amount of aqua complex formed (Fig. S7†).
Since deprotonation of Rh–OH2 can provide a strategically-
placed base for proton abstraction from Cp*, the eﬀect of pH
was investigated (Fig. S8†). Complex 1 in 60% MeOD-d4/40%
D2O was treated with NaOD (in absence of Ag
I). Quantitative full
deuteration was achieved at ambient temperature by the time
the rst 1H NMR spectrum was recorded (ca. 12 min). In
contrast, when the sample of 1 was made acidic with DNO3, no
deuteration was observed aer 12 h. These results are compat-
ible with Rh-OD acting as a base for proton abstraction and
subsequent deuteration of the Cp*.Back exchange
In order to study the reversibility of the deuterium/proton
exchange, we prepared fully deuterated [(D15h
5-Cp*)Rh(bpy)Cl]
PF6 (1D15) and used
2H NMR to show that, as expected, back D/
H exchange was slow (ca. 50%) aer 3 days in 60% MeOH/40%
H2O (Fig. S9†). Such facile deuterium labelling allows a wide
range of reactions to be studied by 2H NMR, e.g. reaction with
biologically-important molecules such as the tripeptide GSH or
stability in complicated biological media such as cell culture
medium, where 1H NMR peaks are heavily overlapped37
(exemplied in Fig. S9†).Chem. Sci., 2018, 9, 3177–3185 | 3179
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View Article OnlineDFT calculations on H/D exchange
These were performed to gain insight into the mechanism of
deuteration and the diﬀerence in behavior between the bpy and
phen complexes, and inactive RhIIIen and IrIIIbpy complexes.
Recently it was shown that the DFT modeling can be very
helpful to elucidate the mechanism of hydrogen formation
catalyzed by RhCp* (bipy) involving the Cp* protonation.38 We
explored a mechanism for H/D exchange involving metal–
ligand-assisted (M–OH) deprotonation of a Cp* ring methyl to
generate a transition state with a bound dianionic ligand
[Me4Cp]CH2]
2 which could then rapidly gain a deuteron from
solvent to generate a –CH2D substituent. Rapid methyl and ring
rotation can lead to the sequential deuteration of all 15 methyl
protons. We modeled the hydroxido adducts using the CAM-
B3LYP functional with a CEP-31G basis set. In the cases ofFig. 2 Key structures of hydroxo and aqua/fulvene complexes from
DFT calculations. Optimized geometries with important weak inter-
actions are shown. Calculated data for IrIII and RhIII systems are
compared in Table S4,† and superposition of relevant OH and H2O
complexes in Fig. S10.† (a) [Rh(Cp*)(bpy)OH]; (b) [Ir(Cp*)(bpy)OH]; (c)
[Rh(Me4Cp]CH2)(bpy)OH2]; (d) [Ir(Me4Cp]CH2)(bpy)OH2]; (e)
[Rh(Cp*)(en)OH]; (f) [Rh(Me4Cp]CH2)(en)OH2]; (g) superimposed
structures of [Me4Cp]CH2]
2 dianion in optimized structure of
[Rh(Me4Cp]CH2)(bpy)OH2] (black) and optimized structure of free
dianion (blue).
3180 | Chem. Sci., 2018, 9, 3177–3185both RhIII and IrIII bpyridine complexes [M(Cp*)(bpy)OH]+, the
optimized structures show a relatively close M–O(H)/HCH2
contact between the bound hydroxide and a Cp* ring methyl
(Fig. 2a), being slightly shorter for Rh (2.165A) than Ir (2.227A),
(Fig. 2b, Table S4†). In contrast, for the en–Rh complex (11), the
hydroxide is oriented so as to optimize H-bonding with an en
NH2 proton, Rh–O(H)/HNH(en) 2.053 A, Fig. 2e.
Next we determined the energies of the structures aer
transfer of a proton from a Cp* methyl group to coordinated
hydroxide, giving coordinated dianionic [Me4Cp]CH2]
2 and
H2O ligands, Fig. 2c and d. This state for Rh is only 35 kJ mol
1
higher in energy than the original R–OH/Cp*-state (Table S5,
Fig. S10†, see the pdb les Rh_bipy_H2O.pdb and Rh_bi-
py_OH.pdb in ESI†). However, for the Ir complex it is 70 kJmol1
higher (Table S5†). The complementary results obtained with
TPSSh functional and QZVP basis set were similar, revealing that
the [Me4Cp]CH2]
2/H2O-coordinated chelates lay 28 kJ mol
1
for Rh and 62 kJ mol1 for Ir above Cp*/M–OH. In the aqua
adduct of the en Rh-complex, the H2O ligand is eﬀectively
outside the rst coordination sphere (Rh–O 3.365A, Fig. 2f). In
addition, the cyclopentadienyl-based dianion shis “upwards”,
with respect to the plane that approximately bisects that dened
by the central ion and chelated nitrogens (Fig. 2f). The super-
imposed structures of both isomers of Rh and Ir bpy complexes,
as well as the Rh en complex are shown in Fig. S11.† The energy
barrier associated with the rotation of the cyclopentadienyl ring
is low (calculated 6 kJ mol1), which together with rapid methyl
rotation, would allow sequential deprotonation and deuteration
of each of the ring methyl protons.
Remarkably, the comparison of the geometries of (a) free
deprotonated Cp* ligand (optimized with CAM-B3LYP/CEP-
31G), (b) deprotonated Cp* in the optimized structures of the
complex, and (c) that of the neutral fulvene Cp* derivative
(optimized with CAM-B3LYP/CEP-31G) suggest that the latter
two are close in energy to each other, while the former reveals an
sp3 character of the CH2 carbon (Fig. S12 and S13†). This allows
an alternative description of the complex containing deproto-
nated Cp* as [RhI/IrI(bpy)(H2O)(Me4Cp]CH2)]
+. Thus, depro-
tonation of Cp* might introduce new pathways of activity
including addition reactions of a bound fulvene, and redox
reactions of rhodium.
Our calculations suggest that the p-acceptor strength of the
N,N0-chelated ligand plays an important role in stabilizing the
aqua/dianionic [Me4Cp]CH2]
2 intermediate in which H/D
exchange can readily occur. Within the series of chelates of
varying p-character of the N,N0 ligands, the stability of the
intermediates increases with increasing p-acceptor character of
the ligand. When we increased the p-acceptor strength by
adding strongly electron-withdrawing groups as in 1,2-diimino-
4,5-dicyanobenzene, the energy diﬀerence decreased to only
13 kJ mol1 above the OH adduct (Table S5).† Interestingly, the
energy diﬀerence for each Ir system is systematically
35–40 kJ mol1 higher in energy than that for the corresponding
Rh complexes (Table S5†). Thus, DFT modeling implies that the
stability of the dianion of the intermediate (or formation of
RhI/IrI fulvene complex) is related to delocalization of the
negative charge onto the N,N0-chelated ligand via the d-orbitalsThis journal is © The Royal Society of Chemistry 2018
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View Article Onlineof the metal. This is facilitated by the p-acceptor character of
the N,N0 ligand and is less eﬀective for Ir than for Rh. Alterna-
tively, the enhanced p-acceptor character of the N,N0-chelate
stabilizes the lower RhI oxidation state.Reactions with GSH
Since ene–thiol reactions are well known, and glutathione (GSH,
g-L-Glu-L-Cys-Gly) is prevalent in cells at millimolar concentra-
tions, reactions of GSH were studied with 1 under conditions in
which activation of Cp* ringmethyls was expected. A solution of 1
and excess GSH at pH 7 gave rise only to MS peaks assignable to
[(h5-Cp*)Rh(bpy)(SG)]. Interestingly, the presence of GSH
restricted, but did not prevent, ring methyl deuteration (up to 7
days incorporated at pH 7 aer 3 days at 310 K, Fig. S14†),
DFT calculations on interactions with GSH and modelling (a)
[(Cp*)Rh(bpy)(GS)]/H2O, (b) [(Cp*)Rh(bpy)(OH)]
+/GSH, (c)
[Rh(Me4Cp]CH2)(bpy)(OH2)]
+/GSH, and (d) [Rh(Me4Cp]
CH2)(bpy)]
+/GSH/H2O, revealed [Rh(bpy)Cp*(SG)] as the most
stable complex (Fig. S15†) formed by coordination of deproto-
nated GS sulfur rather than an ene–thiol adduct. Interestingly,
the adduct is further stabilized by specic interaction of
a deprotonated GS carboxylate group with a Cp* methyl group
and bpy 5-H and 6-H (2.50, 2.64 and 2.30A, respectively).Reaction with N-methylmaleimide
Attempts were made to trap a RhI–bound fulvene intermediate
via [4+2] cyclo-addition between the dienophile, N-methyl-
maleimide, and complex 1. Even aer 5 days at 310 K no such
adduct was observed by 1H NMR or MS, presumably due to
steric crowding by the Cp* ring methyls hindering approach of
the dienophile. However, N-methylmaleimide clearly interacted
with complex 1, [(h5-Cp*)Rh(bpy)Cl]PF6, since with 2mol equiv.
of N-methylmaleimide present in 60% MeOD-d4/40% D2O,
complete deuteration was not observed even aer 7 days, rather
MS peaks for all D1 to D15 sequential steps (Fig. 3a) were
present. With 4 mol equiv. of N-methylmaleimide, only D1–D9
species were observed aer 7 days (Fig. 3b). A DFT study sug-
gested that N-methylmaleimide interacts strongly with the
coordinated water in the fulvene intermediate through a short
maleimide C]O/H–OH bond of 1.68 A rather than attacking
the fulvene double bonds (Fig. S16†). The diﬀerence in energy ofFig. 3 Eﬀect of N-methylmaleimide on deuteration of [(h5-Cp*)
Rh(bpy)Cl]+, 1, in 60% MeOD-d4/40% D2O after 7 days at 310 K
monitored by MS. (a) 2 mol equiv. and (b) 4 mol equiv. N-methyl-
maleimide. The red lines show the isotopic distribution for the non-
deuterated complex.
This journal is © The Royal Society of Chemistry 2018the complex–maleimide pair and the sum of the energies of the
isolated complex and maleimide is 50 kJ mol1. Thus the ful-
vene is too crowded to allow a strong interaction with the
dienophile, but the strong interaction of N-methylmaleimide
with coordinated H2O may result in lower acidity, thus
explaining the lack of deuteration.Trapping the RhI–fulvene intermediates
[4+2] Diels–Alder reactions with the exocyclic double bond of
fulvene as dienophile have been reported in the literature.30,31
The conjugated dienes, isoprene and (9Z,11E)-linoleic acid,
were used in attempts to trap the possible fulvene intermediate
as [4+2] cyclo-addition Diels–Alder adducts. These are both
biologically-important, natural dienes. Isoprene is the most
abundant hydrocarbon in human breath, with an estimated
human production of 17 mg per day.32,33 (9Z,11E)-Linoleic acid
is a common dietary conjugated fatty acid of much interest
because of its potential health eﬀects.34,35
First, the reaction between complex 1 in 60% MeOD-d4/40%
D2O at 310 K and isoprene was studied, since isoprene was ex-
pected to oﬀer minimal steric hindrance for the reaction with
the proposed exocyclicfulvene C]CH2. The ESI-MS spectra
clearly indicated formation of a [4+2] cyclo-addition adduct,
with the peaks at m/z ¼ 497.1225 assignable to the RhI complex
(13+H)+ (Fig. 4). HR-MS data conrmed the formulations
C25H30ClN2Rh, Table S6.† Therefore, the data provide strong
evidence for the formation of a fulvene intermediate during
Cp*–CH3 activation. As expected, adduct formation hinders
deuteration. ESI-MS data suggested that the RhI–Cl bond in the
fulvene adduct is weak, giving rise to the peak at 461.1459
assignable to [13-Cl]+. This is consistent with the report of a very
long RhI–Cl bond (ca. 2.55 A) in a RhI–(Cp*H) complex.27 DFT
calculations indicated lengthening of the Rh–Cl bond by 0.2 AFig. 4 Characterization of the Diels–Alder adduct of complex 1 with
isoprene (complex 13) by ESI-MS and MS-MS. The mass spectrum
shows the formation of the fulvene-isoprene [4+2] cyclo-addition
adduct with coordination of h4-1,2,3,4,8-pentamethylspiro[4,5]deca-
1,3,7-triene to RhI, and its fragmentation by MS-MS (blue box).
Chem. Sci., 2018, 9, 3177–3185 | 3181
Fig. 5 600 MHz 1H NMR characterization of the isoprene adduct
complex 13 in 60% MeOD-d4/40% D2O after 3 days at 310 K. dH 9.09
(d, 2H, J ¼ 6.0 Hz), 8.51 (d, 2H, J ¼ 6.1 Hz), 8.17 (t, 2H, J ¼ 8.0 Hz), 7.67
(dd, 2H, J1¼ 8.1 Hz, J2¼ 6.2 Hz), 5.44 (t, 1H, J¼ 8.6 Hz), 2.10 (t, 2H, J¼
7.0 Hz), 1.68 (s, 6H), 1.63 (s, 3H), 1.55 (s, 4H), 1.47 (s, 6H). The peaks
form excess isoprene (10 mol equiv.) from 4.9–5.2 ppm are shown in
Fig. S19.†. 2D COSY NMR data (Fig. S20†) indicated the coupling of
peak “f” (1.55 ppm) with peak “g” (2.10 ppm), and peak “k” (1.55 ppm)
with “e” (5.43 ppm). The 2D NOESY spectrum (Fig. S21†) indicated
cross-correlation of peak “g” (2.10 ppm) with peaks “h” (1.47 ppm) and
“k” (1.55 ppm) suggesting that these protons are closer than ca. 5 A˚ (for
a model see Fig. S21†).
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View Article Onlinein the RhI system compared to RhIII, making a square-planar
RhI (4d8) adduct accessible (Fig. S17†).
Adduct formation was also evident from LC-MS data
(Fig. S18†), showing a reverse-phase HPLC peak at 25.6 min with
an m/z of 461.16 assignable to [13-Cl]+, as was also observed by
ESI-MS.Fig. 6 Electronic energy proﬁle for the reaction of [(Cp*)Rh(bpy)Cl]+ wi
31g, solvent ¼ water, IEFPCM model). The pdb ﬁles (pdb ﬁles bp1-6.pdb
3182 | Chem. Sci., 2018, 9, 3177–3185The formation such a [4+2] cyclo-addition adduct was further
conrmed by 1H NMR studies. Time-dependent 600 MHz 1H
NMR spectra of the reaction mixture of complex 1 and isoprene
(10 mol equiv.) in 60%MeOD-d4/40% D2O showed a decrease in
the intensity of the isoprene peaks with time, Fig. S19,†
accompanied by an increase in the intensity of peaks arising
from the formation of the adduct (complex 13). The new peaks
due to formation of the [4+2] cyclo-addition adduct are assigned
in Fig. 5. The assignments to a Diels–Alder cyclo-addition
adduct were made on the basis of 1H COSY and NOESY data
(Fig. S20 and S21†).
The MS and NMR data provide the rst experimental
evidence for the formation of a fulvene intermediate trapped
during the course of Cp*–CH3 activation under such mild
conditions in aqueous media, and this appears to be the rst
report of a Diels–Alder reaction of a metal-bound fulvene in
aqueous solution. There appears to be only one previous report
on the promotion of a Diels–Alder reaction through enhance-
ment of diene reactivity through metal coordination.39 Inter-
estingly, we detected the same Diels–Alder adduct by HRMS
when complex 1 was incubated with isoprene (10 mol equiv.) in
RPMI-1640 cell culture medium supplemented with 10% fetal
calf serum, a typical medium used for culture of cancer cells
(Fig. S22†).
The reaction of [(Cp*)Rh(bpy)Cl]+ with isoprene in water was
modeled using DFT calculations (Fig. 6). The results indicate
the relative stability of the initial RhIII complex with the lowest
energy corresponding to [(Cp*)Rh(bpy)OH]+. The formation of
the Diels–Alder adduct from the fulvene species [(Me4Cp]CH2)
RhI(bpy)OH2]
+ is energetically very favourable (106 kJ mol1),th isoprene in water at neutral pH (calculated using CAM-B3LYP/CEP-
) of the optimised structures of all six species are supplied as ESI.†
This journal is © The Royal Society of Chemistry 2018
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View Article Onlinewhile the corresponding end product [(adduct)RhI(bpy)]+ is
presumably driven by entropic eﬀects, with a calculated energy
diﬀerence between it and the [(adduct)RhIII(bpy)](OH2) of only
3 kJ mol1. The change of the oxidation state is suggested by
the calculated Rh–N bond lengths of 2.141 and 2.192 A for the
species with coordinated water, and 2.106 and 2.102 A for the
nal product.
Next, the reactions of complex 1 with the conjugated fatty
acid, (9Z,11E)-linoleic acid, under similar experimental condi-
tions in water, and in RPMI-1640 cell culture medium supple-
mented with 10% of fetal calf serum, were studied. The HRMS
and MS-MS data again clearly indicated the formation of the
fulvene-diene cyclo-addition adduct (Fig. 7 and S23†), with
peaks at m/z ¼ 673.3235 and 674.3298 assignable to the RhI
complexes [14-Cl]+ and [D114-Cl]
+, respectively. HR-MS data
conrmed the formulations as C38H54N2O2Rh and C38H53DN2-
O2Rh, Table S7.† Interestingly, adduct formation is reversible,
as shown in Fig. S24.† Dilution of the reaction mixture leads to
the regeneration of the parent RhIII complex suggesting
possible use as a drug delivery vehicle.
We investigated the formation of [4+2] cyclo-addition
adducts between the biphenyl-substituted Cp* complex 10, an
active anticancer complex, with isoprene in 60% MeOD-d4/40%
D2O at 310 K. This gave rise to a product complex 15, as evi-
denced by ESI-MS, HRMS and LC-MS data (Fig. S25 and S26†),
which suggested that a similar cyclo-addition adduct was
formed. The peaks at m/z ¼ 623.1928, 624.1980 and 625.2030
are assignable to the RhI complexes [15-Cl]+, [D115-Cl]
+ and
[D215-Cl]
+ respectively (Fig. S25†). HR-MS data conrmed the
formulations C38H36N2Rh, C38H35DN2Rh and C38H34D2N2Rh.
The presence of isomers in the product was evident from LC-MS
data (Fig. S26†), and reect the non-equivalence of methyl
deprotonation sites on the bound CpxPhPh. Two reverse-phaseFig. 7 Mass spectra of complex 1 after reaction with conjugated fatty
acid, (9Z,11E)-linoleic acid showing the formation of the fulvene-
linoleic acid [4+2] cyclo-addition adduct, complex 14.
This journal is © The Royal Society of Chemistry 2018HPLC peaks were detected at 32.3 min with an m/z of 623.49
assignable to [15-Cl]+ and 35.2 min with an m/z 623.48. These
data are in good agreement with the observed ESI-MS results.
They, therefore, establish the formation of RhI–fulvene
intermediates during Cp*–CH3 activation in reactions with
conjugated dienes which are abundant in the body. These
observations are of particular interest for the future design of
organometallic half-sandwich anticancer complexes.13 For
example, it might be possible to use such conjugates to deliver
and release complexes in specic cellular organelles.Conclusions
It is diﬃcult to activate C–H bonds of hydrocarbons, especially
CH3 groups, in water under mild conditions, but we show that
this is facile for certain RhIII cyclopentadienyl complexes. DFT
calculations revealed the role of strategically-placed Rh-OD
groups in abstracting protons from coordinated Cpx rings
aided by the presence of chelated p-acceptor diamine ligands
such as bpy or phen (Fig. 8). These ligands help to stabilize the
deprotonated Cpx–H dianion. The Cpx ring behaves like
a ‘molecular twister’ with low barriers to rotation about the
Cpx–Rh and ring-CH3 axes, allowing rapid sequential deutera-
tion. The readily prepared deuterated products are useful for 2H
NMR studies in situations where overlap in 1H NMR spectra
hinders studies, for example in cell culture media (Fig. S9†).
The DFT calculations predicted the accessibility of RhI–fulvene
intermediates formed via 2-electron transfer from the dianionic
Cpx2 ligand. We were not able to generate addition products
between the thiol of glutathione and the exocyclic C]CH2, or
with the dienophile N-methylmaleimide, although they can
control the extent of ring deuteration (Fig. 3 and S14†).Fig. 8 Reaction pathways for Cpxmethyl deuteration and RhI fulvene-
diene adduct formation.
Chem. Sci., 2018, 9, 3177–3185 | 3183
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View Article OnlineHowever, the trapping of the RhI–fulvene intermediates was
surprisingly facile in Diels–Alder [4+2]-cycloaddition reactions
with natural conjugated dienes. This appears to be the rst
report of metal-assisted in situ formation of a dieneophile, and
trapping of that dieneophile by a Diels–Alder cyclo-addition
reaction of a metal-bound fulvene in aqueous solution.
Adducts with isoprene, an abundant diene in human breath,
and with the common dietary diene conjugated (9Z,11E)-lino-
leic acid formed readily in aqueous solution. They might easily
form in cells, and inuence the redox state of cells and bio-
logical activity of this class of organo–rhodium anticancer
complexes. The Diels–Alder adducts formed readily in biolog-
ical media, e.g. cell culture medium (Fig. S22 and S23†) and
since they are reversible (Fig. S24†), open up the possibility of
designing novel drug targeting and delivery systems. Interest-
ingly, the most active anticancer complexes in the limited set we
have studied here, are those that have activated Cpx rings
(Table S3†). The possible involvement of such Diels–Alder
adducts in the biological activity of this class of complexes will
be studied in future work.Conﬂicts of interest
There are no conicts to declare.Acknowledgements
This work was supported by the ERC (grant no. 247450), EPSRC
(grant no. EP/F034210/1), Warwick Institute of Advanced
Studies, Alexander von Humboldt scholarship for J. J. S. B., The
Royal Society and SERB (Newton International Fellowship for
S. B.), China Scholarship Council (studentship for F. C.) and
Bruker UK Ltd (Warwick Collaborative Studentship for
C. A. W.). V. S. and J. A. W. acknowledge support by the research
initiative NANOKAT and the German Federal Ministry of
Education and Research (BMBF), as well as Allianz fu¨r
Hochleistungsrechnen Rheinland-Pfalz (AHRP) for providing
CPU-time within the project TUK-SPINPLUSVIB. We also thank
Dr David Fox (University of Warwick) and members of COST
Action CM1105 for stimulating discussions.Notes and references
1 J. M. O'Connor and C. P. Casey, Chem. Rev., 1987, 87, 307–
318.
2 J. F. Hartwig, Organotransition Metal Chemistry: From Bonding
to Catalysis, University Science Books, Sausalito, CA, 2010.
3 J. D. Blakemore, R. H. Crabtree and G. W. Brudvig, Chem.
Rev., 2015, 115, 12974–13005.
4 D. L. Huang, D. J. Vinyard, J. D. Blakemore, S. M. Hashmi
and R. H. Crabtree, Organometallics, 2017, 36, 199–206.
5 A. J. Bloomeld, A. J. Matula, B. Q. Mercado, V. S. Batista and
R. H. Crabtree, Inorg. Chem., 2016, 55, 8121–8129.
6 R. Pettinari, F. Marchetti, C. Pettinari, F. Condello, A. Petrini,
R. Scopelliti, T. Riedel and P. J. Dyson, Dalton Trans., 2015,
44, 20523–20531.3184 | Chem. Sci., 2018, 9, 3177–31857 G. Song, F. Wang and X. Li, Chem. Soc. Rev., 2012, 41, 3651–
3678.
8 N. Schro¨der, J. Wencel-Delord and F. Glorius, J. Am. Chem.
Soc., 2012, 134, 8298–8301.
9 C. Li and J. Xiao, J. Am. Chem. Soc., 2008, 130, 13208–13209.
10 C. G. Hartinger, N. Metzler-Nolte and P. J. Dyson,
Organometallics, 2012, 31, 5677–5685.
11 Z. Liu and P. J. Sadler, Acc. Chem. Res., 2014, 47, 1174–1185.
12 Z. Almodares, S. J. Lucas, B. D. Crossley, A. M. Basri,
C. M. Pask, A. J. Hebden, R. M. Phillips and
P. C. McGowan, Inorg. Chem., 2014, 53, 727–736.
13 J. J. Soldevila-Barreda, A. Habtemariam, I. Romero-Canelo´n
and P. J. Sadler, J. Inorg. Biochem., 2015, 153, 322–333.
14 Z. Liu, I. Romero-Canelo´n, B. Qamar, J. M. Hearn,
A. Habtemariam, N. P. E. Barry, A. M. Pizarro,
G. J. Clarkson and P. J. Sadler, Angew. Chem., 2014, 126,
4022–4027.
15 D. Balcells, E. Clot and O. Eisenstein, Chem. Rev., 2010, 110,
749–823.
16 J. E. McMurry, Organic Chemistry, Brooks-Cole, Pacic Grove,
CA, 5th edn, 2000.
17 A. McNally, B. Haﬀemayer, B. S. L. Collins and M. J. Gaunt,
Nature, 2014, 510, 129–133.
18 S. Bag, R. Jayarajan, U. Dutta, R. Chowdhury, R. Mondal and
D. Maiti, Angew. Chem., Int. Ed., 2017, 56, 12538–12542.
19 T. Patra, S. Bag, R. Kancherla, A. Mondal, A. Dey,
S. Pimparkar, S. Agasti, A. Modak and D. Maiti, Angew.
Chem., Int. Ed., 2016, 55, 7751–7755.
20 S. Agasti, A. Dey and D. Maiti, Chem. Commun., 2017, 53,
6544–6556.
21 D. C. McAteer, E. Javed, L. Huo and S. Huo, Org. Lett., 2017,
19, 1606–1609.
22 J. W. Kang and P. M. Maitlis, J. Organomet. Chem., 1971, 30,
127–133.
23 J. E. Bercaw, R. H. Marvich, L. G. Bell and H. H. Brintzinger,
J. Am. Chem. Soc., 1972, 94, 1219–1238.
24 C. S. Wei, C. A. Jime´nez-Hoyos, M. F. Videa, J. F. Hartwig and
M. B. Hall, J. Am. Chem. Soc., 2010, 132, 3078–3091.
25 G. Ciancaleoni, S. Bolano, J. Bravo, M. Peruzzini, L. Gonsalvi
and A. Macchioni, Dalton Trans., 2010, 39, 3366–3368.
26 L. M. A. Quintana, S. I. Johnson, S. L. Corona, W. Villatoro,
W. A. Goddard III, M. K. Takase, D. G. VanderVelde,
J. R. Winkler, H. B. Gray and J. D. Blakemore, Proc. Natl.
Acad. Sci. U. S. A., 2016, 113, 6409–6414.
27 C. L. Pitman, O. N. L. Finster and A. J. M. Miller, Chem.
Commun., 2016, 52, 9105–9108.
28 Y. Peng, M. V. Ramos-Garce´s, D. Lionetti and
J. D. Blakemore, Inorg. Chem., 2017, 56, 10824–10831.
29 W. C. Henke, D. Lionetti, W. N. G. Moore, J. A. Hopkins,
V. W. Day and J. D. Blakemore, ChemSusChem, 2017, 10,
4589–4598.
30 P. Preethalayam, K. S. Krishnan, S. Thulasi, S. S. Chand,
J. Joseph, V. Nair, F. Jaroschik and K. V. Radhakrishnan,
Chem. Rev., 2017, 117, 3930–3989.
31 A. Z. Bimanand, Y. N. Gupta, M. J. Doa, T. A. Eaton,
K. N. Houk and F. R. Fronczek, J. Org. Chem., 1983, 48,
403–405.This journal is © The Royal Society of Chemistry 2018
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
M
ar
ch
 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
4/
05
/2
01
8 
09
:5
5:
57
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online32 D. Gelmont, R. A. Stein and J. F. Mead, Biochem. Biophys. Res.
Commun., 1981, 99, 1456–1460.
33 J. King, H. Koc, K. Unterkoer, P. Mochalski,
A. Kupferthaler, G. Teschl, S. Teschl, H. Hinterhuber and
A. Amann, J. Theor. Biol., 2010, 267, 626–637.
34 G. Fuke and J. L. Nornberg, Crit. Rev. Food Sci. Nutr., 2017,
57, 1–7.
35 A. A. Hennessy, P. R. Ross, G. F. Fitzgerald and C. Stanton,
Lipids, 2016, 51, 377–397.This journal is © The Royal Society of Chemistry 201836 M. A. Scharwitz, I. Ott, Y. Geldmacher, R. Gust and
W. S. Sheldrick, J. Organomet. Chem., 2008, 693, 2299–2309.
37 J. L. Wagstaﬀ, R. J. Masterton, J. F. Povey, C. M. Smales and
M. J. Howard, PLoS One, 2013, 8, e77195.
38 S. I. Johnson, H. B. Gray, J. D. Blakemore and W. A. Goddard
III, Inorg. Chem., 2017, 56, 11375–11386.
39 W. Liu, F. You, C. J. Mocella andW. D. Harman, J. Am. Chem.
Soc., 2006, 128, 1426–1427.Chem. Sci., 2018, 9, 3177–3185 | 3185
